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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S440markers, were able to differentiate in vitro and in vivo into all three
germ layers (ectoderm, endoderm, and mesoderm), displayed normal
karyotypes, and showed silenced expression of retroviral genes.
During early differentiation towards mesendoderm, CD long iPSCs
maintained an epithelial-like morphology and had reduced expres-
sion of mesendoderm and epithelial-to-mesechymal transition (EMT)
genes compared to CD short and WT iPSCs. Further differentiation of
iPSCs towards chondroprogenitors revealed that CD long iPSCs had
reduced levels of proteoglycans and reduced expression of cartilage
genes compared to CD short and WT iPSCs. All iPSC lines were able to
form cartilage tissue expressing type II collagen and proteoglycans in
vivo with no gross morphological differences between WT and CD
tissues.
Conclusions: iPSCs can be derived from patients with heterozygous
mutations in SOX9 as SOX9 is not known to play a key role in pluri-
potency or reprogramming. CD short iPSCs differentiated efﬁciently
towards mesendoderm and chondroprogenitors, similar to WT iPSCs.
However, CD long iPSCs exhibited delayed differentiation towards
mesendoderm, affecting their capacity to differentiate towards
chondroprogenitors. This suggests SOX9 may play a role in speciﬁ-
cation to mesendoderm, one of the embryonic origins of cartilage
tissue. We have shown that different mutations in SOX9 can lead to
different phenotypic outcomes whose mechanisms can be inves-
tigated using iPSCs as a human in vitro model. Since SOX9 controls
expression of key extracellular matrix genes found in embryonic and
adult cartilage tissue, CD iPSC-derived chondroprogenitors can be
used to elucidate pathways in which aberrant expression of SOX9
leads to improper expression of these genes. Further, we have
established a differentiation protocol and set of assays that can be
applied to disease modelling of iPSCs derived from patients with
osteoarthritis.
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CHEMOTAXIS OF CULTURED HUMANMESENCHYMAL STEM CELLS TO
OSTEOARTHRITIC CARTILAGE AND SYNOVIUM
M.J. Leijs, P.K. Bos, J.A. Verhaar, M.J. Hoogduijn, G.J. van Osch. Erasmus
MC, Rotterdam, Netherlands
Purpose:Mesenchymal stem cells (MSCs) are promising candidates for
cell therapy in osteoarthritis (OA). MSCs can differentiate to generate
repair cartilage tissue and they have potential immunomodulatory and
anti-inﬂammatory effects on synovium and cartilage. To be therapeutic
in OA, MSCs need to survive after intra-articular injection, probably by
migration towards or into affected tissues. Chemotactic factors secreted
by OA tissues and expression of chemotactic factor receptors by MSCs
could be involved in this migration. We studied the effect of the OA
environment on the migration of MSCs in culture and we studied
whether we could prime MSCs with inﬂammatory factors to inﬂuence
the expression of chemotactic factor receptors and thereby improve the
migration capacity.
Methods: MSCs were cultured in monolayer in serum-free medium
with 1% ITS at 20% O2 with(out) 50ng/ml, 20ng/ml or 1 ng/ml IFNg and
TNFa for 24 hours or with(out) 50% synovial ﬂuid (SF) of OA patients or
healthy donors for 48 hours. The expression of chemotactic factor
receptors CXCR1, CXCR3, CXCR4, CCR1, CCR4, CCR5, PDGFRa, PDGFRb
and CX3CR1 by MSCs was analysed by RT-PCR (related to HPRT as
housekeeper) and FACS. Chemotactic factors fractalkine, MCP-3, PDGF-
BB, MIP-1a, MIP-1b, MDC, PDGF-AA, IP10, IL-8 and MCP-1 secreted in
themedium by OA cartilage and synovium of six donors weremeasured
with a 10-plex milliplex assay. For the chemotaxis assay 6,000 MSCs
were seeded in transwell inserts (8.0um pores) and placed in 24-well
plates with OA synovium or cartilage conditioned medium (CM) for 18
hours. Migrated MSCs on the outside of the transwell membrane were
stained and counted.
Results: All chemotactic factor receptor genes were expressed in cul-
tured MSCs except for CXCR1. MSCs exposed to OA SF lead to an
increased mRNA expression of CCR1 and PDGFRa and a decreased
expression of PDGFRb (ﬁgure 1).
The chemotactic factors that bind on these receptors were present in OA
synovium. They were secreted by both OA cartilage and synovium; in
particular high amounts of MDC, IL-8 and MCP-1 were detected in the
CM. Additionally, differences in the composition of the chemokines
secreted by synovium and cartilage were obvious: synovium CM con-
tained higher amounts of MIP-1a and MIP-1b and cartilage CM con-
tained higher amounts of PDGF-AA and IP10.The chemotaxis assay then demonstrated that signiﬁcantly more MSCs
migrated towards OA synovium and cartilage CM compared to control
medium (ﬁgure 2).
Priming the MSCs with inﬂammatory factors IFNg and TNFa increased
the mRNA expression of CCR1 and CCR4 and decreased PDGFRa and
PDGFRbwith a clear dose response effect on the expression of CCR1 and
PDGFRa. The decreased expression of PDGFRa could be conﬁrmed with
FACS analyses. OA CM still had an chemotactic effect on primed MSCs,
however the chemotactic effect of OA CM was stronger on non-primed
MSCs compared to primed MSCs. http://ﬁles.abstractsonline.com/CTRL/
51/E/C61/29B/95C/475/69C/E31/591/FAC/899/02/g833_1.jpg
Fig. 1. MSCs exposed to OA SF; OA SF increased gene expression of CCR1
and PDGFRa (A-B) and decreased gene expression of PDGFRb (C). *p <
0.05; mean  SD; (OA) osteoarthritis, (SF) synovial ﬂuid.
Fig. 2. MSCs migrate to OA synovium and cartilage CM. *** p < 0.001;
mean  SD; (syn CM) synovium conditioned medium, (cart CM) cartilage
conditioned medium.Conclusion: MSCs expressed mRNA for chemo-
tactic factor receptors and migrated towards chemotactic factors
secreted by OA synovium and cartilage. Based on our in-vitro data, OA
SF will probably not have a negative effect on the expression of the
chemotactic factor receptors of intra-articularly injected MSCs. Priming
MSCs in culture with inﬂammatory factors before intra-articular
injection with the goal to improve the migration potential, inﬂuenced
the expression of different chemotactic factor receptor in MSCs, how-
ever did not improve chemotaxis. These data suggest that we should be
careful with priming MSCs (with inﬂammatory factors) to activate their
capacities or with injecting them into an inﬂammatory environment
and encourage further research to improve and optimize the ther-
apeutic capacities of MSCs for OA.
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TGFbMODULATES ITS OWN SIGNALING IN CHONDROGENIC CELLS BY
INDUCING ALK5 AND DAMPENING ALK1
L.M. de Kroon y,z, E.N. Blaney Davidson y, R. Narcisi z, M. Cleary z,
P.M. van der Kraan y, G.J. van Osch z. yRadboud Univ. Med. Ctr., Nijmegen,
Netherlands; z Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose:Osteoarthritis and trauma lead to cartilage lesions that remain
unrepaired because cartilage is a tissue with poor regenerative capacity.
Bone marrow-derived mesenchymal stem cells (BMSCs) are a promis-
ing cell source to treat cartilage defects due to their capacity to
